Genomtec Balance Sheet Health
Financial Health criteria checks 4/6
Genomtec has a total shareholder equity of PLN5.6M and total debt of PLN397.0K, which brings its debt-to-equity ratio to 7%. Its total assets and total liabilities are PLN17.2M and PLN11.6M respectively.
Key information
7.0%
Debt to equity ratio
zł397.00k
Debt
| Interest coverage ratio | n/a |
| Cash | zł6.79m |
| Equity | zł5.64m |
| Total liabilities | zł11.56m |
| Total assets | zł17.21m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 4VI's short term assets (PLN8.3M) exceed its short term liabilities (PLN7.4M).
Long Term Liabilities: 4VI's short term assets (PLN8.3M) exceed its long term liabilities (PLN4.2M).
Debt to Equity History and Analysis
Debt Level: 4VI has more cash than its total debt.
Reducing Debt: Insufficient data to determine if 4VI's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 4VI has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 4VI has less than a year of cash runway if free cash flow continues to reduce at historical rates of 34.8% each year